KATHMANDU: Patients in Nepal will soon receive sickle cell anemia medication that was created and tested in India, according to Prime Minister KP Sharma Oli. The Tharu group is especially impacted by the illness, he said, so national health assistance should prioritize this.
Oli urged the graduating physicians to get ready to distribute this novel medication during his remarks at the 13th Convocation Ceremony of the BP Koirala Institute of Health Sciences (BPKIHS) in Dharan. "Search and investigation can lead to discovery" and "honesty and diligence yields achievement," he underlined, and he urged the new physicians to follow these principles throughout their medical careers.
In an effort to motivate the graduates, the Prime Minister also brought up Nepal's long history in the medical field, citing Rishi Charak, who is regarded as one of the pioneers of medicine. The administration is dedicated to providing all residents, especially those in vulnerable neighborhoods, with access to healthcare, he said.
PM Oli reaffirmed the government's resolve to expand education and healthcare in Nepal. He highlighted efforts to increase the number of medical student quotas at BPKIHS to respond to the country's need for more medical professionals.
Oli reaffirmed the government's commitment to enhancing Nepal's healthcare system's accessibility and infrastructure in his closing remarks. He expressed hope that the distribution of innovative medications, including the medication for sickle cell anemia, can be efficiently managed for the benefit of individuals in need with the help of recently graduated medical professionals.
